К содержанию
Dr. Tara EinullaevaMedical oncologist

Treatment 5 min

Palliative chemotherapy: why it is given if it will not cure

What “palliative” chemotherapy means, how it differs from hospice and palliative care, what to expect and how to weigh benefit against risk.

Written and medically reviewed by

Dr. Tara Einullaeva

Medical oncologist, 9 years in practice. Credentials · reviewed 23 October 2026

“Palliative” describes the goal of treatment: not a complete cure, but control of the disease: slowing tumour growth, reducing symptoms and preserving quality of life. It is active treatment, not a refusal of treatment.

How it differs from palliative care

Palliative chemotherapy is one type of anticancer treatment for advanced disease. Palliative (supportive) care is a separate field: pain relief, help with breathlessness and nausea, psychological support. It is recommended alongside main treatment in metastatic cancer, not only at the end.

How benefit and risk are weighed

  • Expected effect: how long the disease may stay under control and what that means for symptoms.
  • Toxicity: which side effects are likely and how well you are likely to tolerate them.
  • Your goals: what matters more to you: time, how you feel, the ability to work or travel.
  • Alternatives: other drugs, supportive therapy, observation.

How to tell whether treatment is worth continuing

The effect of palliative chemotherapy is judged by several signs together, not by one number.

  • Symptoms: whether pain, cough and weakness have eased and appetite has improved.
  • Scans: CT or MRI after several courses; stable disease also counts as a good result.
  • Tolerability: nausea, weakness, blood counts, weight and the ability to do usual things.
  • Your own assessment: if treatment takes more strength than it gives, that is a reason to discuss changing the regimen or pausing. The decision is made together with the doctor.

What “palliative” means

In oncology, palliative chemotherapy means treatment whose goal is not complete cure but control of the disease, relief of symptoms and longer life with acceptable quality. It is not the same as “hospice” or “treatment is over”. Many patients receive it for months and years and continue working and living as usual.

The word “palliative” often frightens. If the doctor has said it, ask them to explain exactly what goal they set and how they will judge the result.

How it differs from curative treatment

  • Goal. Curative treatment aims at cure, palliative at control.
  • Intensity. With a palliative approach, regimens with lower toxicity are chosen more often, and doses are adjusted to how you feel.
  • Duration. Treatment continues while it helps and is well tolerated, not a fixed number of courses.
  • Review. The regimen can be changed, paused or moved to maintenance drugs. For some tumours palliative treatment is combined with local methods: radiotherapy, surgery for complications.

When to ask questions

If palliative chemotherapy is proposed, it makes sense to clarify:

  • What is the goal: shrinkage, stability or symptom relief?
  • Which molecular tests were done, and are there targeted or immune options that may work better?
  • What effect is expected and which side effects are most likely?
  • What happens if you decline or postpone?
  • How soon and by what will the result be assessed? If answers are vague, that is a good reason for a second opinion.

What regimens exist and how they are chosen

  • A single drug (monotherapy) is gentler and suits weakened and older patients.
  • Combinations act stronger but are more toxic; they are chosen when a quick response is needed or the tumour is aggressive.
  • Maintenance treatment after response: gentler drugs to hold the result.
  • Targeted and immune drugs are often more effective and better tolerated, so the molecular profile is checked before chemotherapy. The choice depends on tumour type, previous treatment, liver and kidney function, condition and your goals.

Side effects and how they are reduced

  • Nausea and vomiting: modern antiemetics (5-HT3 and NK1 antagonists, dexamethasone) remove most of the problem; they must be taken on schedule, not after nausea appears.
  • Low white cells: raises infection risk; with temperature above 38 °C call the doctor urgently. Growth factors are sometimes prescribed.
  • Weakness and anaemia: tests are checked and corrected if needed.
  • Mucositis, diarrhoea, neuropathy, hair loss depend on the drugs; some can be prevented or reduced.
  • Doses can be reduced. If side effects are strong, the doctor adjusts dose or interval, not necessarily stopping treatment.

What to consider before and during treatment

  • Find out whether more suitable targeted or immune options exist for your molecular profile.
  • Agree a plan for assessing the effect: when the CT is, which tests.
  • Decide in advance who will accompany you and help at home.
  • Discuss nutrition, weight and physical activity: they affect tolerance.
  • Add psychological support if anxiety is strong.
  • Make a list of questions for each appointment. If the regimen seems too harsh or, on the contrary, too weak, a document-based second opinion helps check the choice.

What to ask your doctor

  • What is the goal of this course and how will we know it is working?
  • When will we assess the effect and what will we change if it is not working?
  • What can be done to make treatment easier to tolerate?

If you doubt whether this therapy is right for you, I can help you weigh the options at a consultation.

Sources

  1. Palliative Care for Patients With Cancer: ASCO Guideline Update — ASCO, 2024

Watch me explain this on video

Short videos on my Instagram (in Russian)

Frequently asked questions

This article is for information only and does not replace a consultation with your treating doctor. Decisions about tests and treatment are made by the doctor who looks after you.